University of Texas, El Paso

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Texas, El Paso sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 8 currently recruiting 7 completed top decile by trial count

University of Texas, El Paso: 17 sponsored US clinical trials, 8 recruiting.

University of Texas, El Paso sponsors 17 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Central Pain Syndrome, with 2 trials.

Top-decile sponsor footprint

University of Texas, El Paso ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

17 total, page 1 of 1

RECRUITING NA

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

NCT07221266

RECRUITING NA

Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery

NCT07661849

RECRUITING NA

Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

NCT06411769

RECRUITING NA

Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism

NCT06722391

RECRUITING NA

Culturally Tailored HPV Psychoeducational Multimedia Intervention

NCT06098690

RECRUITING NA

Upper and Lower Extremity Exercise and Exercise-Induced Hypoalgesia in Knee Osteoarthritis

NCT06105788

RECRUITING NA

Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs

NCT05800899

RECRUITING NA

Improving Glycemic Control With Electrical Stimulation

NCT03947697

NOT YET RECRUITING NA

Acute Cryotherapy on Musculoskeletal Function and Biomarkers

NCT07211412

COMPLETED NA

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

NCT05120869

COMPLETED NA

The Physiological Effects of Acute and Ramp Simulated Altitude Exposure During Simulated Flight Tasks

NCT05867719

COMPLETED NA

Effects of Vagus Nerve Stimulation on Central Pain Sensitivity & Parasympathetic Function in Knee Osteoarthritis

NCT05625178

COMPLETED NA

Retention of Whole-body Training Effects on Ambulatory Function in Children With Cerebral Palsy

NCT04961749

COMPLETED NA

Clinical Effectiveness of Boxing Training in Individuals With Elevated Blood Pressure or Stage 1 Hypertension

NCT06413251

COMPLETED NA

Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity

NCT02745613

TERMINATED NA

Culturally Adapted Brief Intervention for Heavy Drinking Hispanic Men

NCT02429401

COMPLETED NA

Computer-Mediated Versus Face-to-Face Motivational-Type Interviews

NCT06945471

What is open in the University of Texas, El Paso pipeline

8 recruiting of 17 indexed (47% open); 7 completed (41%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Central Pain Syndrome (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas, El Paso: open-pipeline peers nationwide

Peers matched on 17 registered trials and 47% open enrollment, not the therapeutic-area sidebar.

University of Texas, El Paso sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%10%20%30%40%50% Total trials Recruiting share University of Texas, El PasoAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecNRG OncologyNorth Carolina State UniversityNader SanaiPraxis Precision Medicines
University of Texas, El Paso sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas, El Paso sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 47% open enrollment (± trial volume)

What to do with this University of Texas, El Paso page

17 registered trials is a research-attention snapshot, not an endorsement of University of Texas, El Paso or any single study.

  • 8 of University of Texas, El Paso's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Central Pain Syndrome is the condition University of Texas, El Paso studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Central Pain Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas, El Paso pipeline card: 17 registered trials from official public datasets.Report a data error.